Literature DB >> 20357429

MicroRNA profiles of drug-resistant myeloma cell lines.

Reinhold Munker1, Chang-Gong Liu, Cristian Taccioli, Hansjuerg Alder, Nyla Heerema.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20357429      PMCID： PMC2881892          DOI： 10.1159/000302889

Source DB:  PubMed          Journal:  Acta Haematol        ISSN： 0001-5792            Impact factor:   2.195


× No keyword cloud information.
  10 in total

Review 1.  Expression profiling of microRNA using oligo DNA arrays.

Authors:  Chang-Gong Liu; Riccardo Spizzo; George Adrian Calin; Carlo Maria Croce
Journal:  Methods       Date:  2008-01       Impact factor: 3.608

Review 2.  MicroRNA signatures in human cancers.

Authors:  George A Calin; Carlo M Croce
Journal:  Nat Rev Cancer       Date:  2006-11       Impact factor: 60.716

3.  Comparative gene expression analysis of a chronic myelogenous leukemia cell line resistant to cyclophosphamide using oligonucleotide arrays and response to tyrosine kinase inhibitors.

Authors:  Fei Bao; Paula Polk; Mary L Nordberg; Diana M Veillon; Amanda Sun; Michael Deininger; David Murray; Borje S Andersson; Reinhold Munker
Journal:  Leuk Res       Date:  2007-04-02       Impact factor: 3.156

4.  Role of microRNAs in drug-resistant ovarian cancer cells.

Authors:  Antonio Sorrentino; Chang-Gong Liu; Antonio Addario; Cesare Peschle; Giovanni Scambia; Cristiano Ferlini
Journal:  Gynecol Oncol       Date:  2008-09-26       Impact factor: 5.482

5.  Genotypic and phenotypic comparisons of de novo and acquired melphalan resistance in an isogenic multiple myeloma cell line model.

Authors:  Lori A Hazlehurst; Steven A Enkemann; Craig A Beam; Raul F Argilagos; Jeffrey Painter; Kenneth H Shain; Sara Saporta; David Boulware; Lynn Moscinski; Melissa Alsina; William S Dalton
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

Review 6.  Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies.

Authors:  M Mimeault; R Hauke; S K Batra
Journal:  Clin Pharmacol Ther       Date:  2007-09-05       Impact factor: 6.875

7.  Development and characterization of a melphalan-resistant human multiple myeloma cell line.

Authors:  W T Bellamy; W S Dalton; M C Gleason; T M Grogan; J M Trent
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

8.  MicroRNAs regulate critical genes associated with multiple myeloma pathogenesis.

Authors:  Flavia Pichiorri; Sung-Suk Suh; Marco Ladetto; Michael Kuehl; Tiziana Palumbo; Daniela Drandi; Cristian Taccioli; Nicola Zanesi; Hansjuerg Alder; John P Hagan; Reinhold Munker; Stefano Volinia; Mario Boccadoro; Ramiro Garzon; Antonio Palumbo; Rami I Aqeilan; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-26       Impact factor: 11.205

9.  MicroRNA signatures of TRAIL resistance in human non-small cell lung cancer.

Authors:  M Garofalo; C Quintavalle; G Di Leva; C Zanca; G Romano; C Taccioli; C G Liu; C M Croce; G Condorelli
Journal:  Oncogene       Date:  2008-02-04       Impact factor: 9.867

10.  Systematic analysis of microRNA involved in resistance of the MCF-7 human breast cancer cell to doxorubicin.

Authors:  Guo-Qing Chen; Zhi-Wei Zhao; Hong-Ying Zhou; Yuan-Jie Liu; Hui-Jun Yang
Journal:  Med Oncol       Date:  2009-05-02       Impact factor: 3.064
  10 in total
  14 in total

Review 1.  MicroRNA-21 and multiple myeloma: small molecule and big function.

Authors:  Jing Ma; Su Liu; Yafei Wang
Journal:  Med Oncol       Date:  2014-07-01       Impact factor: 3.064

Review 2.  Promises and challenges of MicroRNA-based treatment of multiple myeloma.

Authors:  P Tagliaferri; M Rossi; M T Di Martino; N Amodio; E Leone; A Gulla; A Neri; P Tassone
Journal:  Curr Cancer Drug Targets       Date:  2012-09       Impact factor: 3.428

Review 3.  The role of epigenetics in the biology of multiple myeloma.

Authors:  K Dimopoulos; P Gimsing; K Grønbæk
Journal:  Blood Cancer J       Date:  2014-05-02       Impact factor: 11.037

Review 4.  Microenvironment drug resistance in multiple myeloma: emerging new players.

Authors:  Lucia Di Marzo; Vanessa Desantis; Antonio Giovanni Solimando; Simona Ruggieri; Tiziana Annese; Beatrice Nico; Ruggiero Fumarulo; Angelo Vacca; Maria Antonia Frassanito
Journal:  Oncotarget       Date:  2016-09-13

5.  Methylation-associated Has-miR-9 deregulation in paclitaxel- resistant epithelial ovarian carcinoma.

Authors:  Xiao Li; Qianqian Pan; Xiaoyun Wan; Yuyan Mao; Weiguo Lu; Xing Xie; Xiaodong Cheng
Journal:  BMC Cancer       Date:  2015-07-08       Impact factor: 4.430

Review 6.  Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.

Authors:  Jahangir Abdi; Guoan Chen; Hong Chang
Journal:  Oncotarget       Date:  2013-12

Review 7.  Micro-RNAs, New performers in multiple myeloma bone marrow microenvironment.

Authors:  Jahangir Abdi; Lugui Qiu; Hong Chang
Journal:  Biomark Res       Date:  2014-05-30

Review 8.  MicroRNA: important player in the pathobiology of multiple myeloma.

Authors:  Chonglei Bi; Wee Joo Chng
Journal:  Biomed Res Int       Date:  2014-06-03       Impact factor: 3.411

9.  Integrative analysis of differential miRNA and functional study of miR-21 by seed-targeting inhibition in multiple myeloma cells in response to berberine.

Authors:  Xiaochuang Luo; Jingyi Gu; Rongxuan Zhu; Maoxiao Feng; Xuejiao Zhu; Yumin Li; Jia Fei
Journal:  BMC Syst Biol       Date:  2014-07-07

10.  Proteomic analysis of gossypol induces necrosis in multiple myeloma cells.

Authors:  Renhua Xu; Enbing Tian; Haiping Tang; Chongdong Liu; Qingtao Wang
Journal:  Biomed Res Int       Date:  2014-08-14       Impact factor: 3.411
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.